Sigma Planning Corp Sells 10,769 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Sigma Planning Corp reduced its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 43.4% in the 4th quarter, HoldingsChannel reports. The firm owned 14,071 shares of the pharmacy operator’s stock after selling 10,769 shares during the period. Sigma Planning Corp’s holdings in Walgreens Boots Alliance were worth $367,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Highlander Capital Management LLC bought a new position in Walgreens Boots Alliance during the 4th quarter valued at about $26,000. Venturi Wealth Management LLC raised its stake in shares of Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 981 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 845 shares during the last quarter. Rocky Mountain Advisers LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $30,000. Finally, Planned Solutions Inc. bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $34,000. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Up 0.6 %

Shares of NASDAQ WBA opened at $17.70 on Friday. The stock has a market cap of $15.27 billion, a P/E ratio of -2.53, a P/E/G ratio of 1.09 and a beta of 0.73. The firm has a 50 day moving average price of $20.01 and a 200 day moving average price of $21.77. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. Walgreens Boots Alliance, Inc. has a 52-week low of $17.49 and a 52-week high of $35.38.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.16 earnings per share. Analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on WBA shares. Bank of America dropped their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research note on Tuesday, March 26th. TD Cowen dropped their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday, April 3rd. SVB Leerink dropped their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Finally, Truist Financial reiterated a “hold” rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Four analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $24.36.

Insider Activity

In related news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, Director Valerie B. Jarrett purchased 4,456 shares of Walgreens Boots Alliance stock in a transaction dated Monday, January 29th. The stock was bought at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the acquisition, the director now directly owns 4,456 shares of the company’s stock, valued at $99,992.64. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. Insiders purchased 13,456 shares of company stock worth $270,423 over the last quarter. 17.40% of the stock is currently owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.